Holding Big Pharma Accountable Remains Top Priority for American Voters
For Immediate Release
Contact: Jon Conradi
Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Wednesday ahead of President Biden’s introduction of the “American Families Plan” in an address to Congress.
“We thank the President for correctly recognizing the importance of solutions to lower out-of-control drug prices and hold Big Pharma accountable,” said CSRxP executive director Lauren Aronson. “We look forward to working with the administration and Congress to ensure solutions to lower drug prices are addressed in the American Families Plan.”
“The crisis of prescription drug affordability remains a top concern for American voters and Big Pharma shows no sign of slowing its egregious pricing and anti-competitive practices,” Aronson continued. “The American people are counting on policymakers to deliver relief by advancing solutions to promote drug pricing transparency, foster generic and biosimilar competition and reform Medicare Part D to deliver out-of-pocket relief for seniors, give drug companies significant skin in the game in the catastrophic phase of coverage and keep price hikes below the rate of inflation.”
A poll commissioned by CSRxP and conducted by Morning Consult earlier this year found that Americans overwhelmingly expect Congress and the new administration to move urgently to follow-through on campaign promises to lower drug prices and hold drug companies accountable:
Read more on CSRxP’s poll conducted earlier this year HERE.
Learn more about market-based solutions to hold Big Pharma accountable and lower prescription drug prices HERE.